ArticleEuropean journal of neurology2025

Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy.

Andreu Vilaseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.